Skip to main content

Table 1 Model inputs

From: Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma

Model input

Base case value

Distribution

References

Transition probabilities

 W to S

0.097

β(SD: 0.029)

[9]

 W to A

0.004

β(SD: 0.002)

 S to W

0.817

β(SD: 0.038)

 S to A

0.007

β(SD: 0.003)

 A to W

0.271

β(SD: 0.044)

 A to S

0.052

β(SD: 0.046)

Utility

 Well-controlled

0.99

β(SD: 0.016)

[9]

 Sub-optimal control

0.70

β(SD: 0.072)

 Asthma exacerbation

0.31

β(SD: 0.070)

FeNO-SC effectiveness

 Relative risk of reduction of exacerbations

0.76

LogN(SD: 0.274)

[10,11,12,13,14,15,16,17,18]

  1. Well-controlled: W
  2. Sub-optimal control: S
  3. Asthma exacerbation: A